Double Medical Technology Inc. (002901.SZ)
CNY 30.74
(-0.03%)
CNY 30.74
(-0.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 990.96 Million CNY | -9.93% |
| 2022 | 1.1 Billion CNY | -34.64% |
| 2021 | 1.68 Billion CNY | 23.53% |
| 2020 | 1.36 Billion CNY | 26.59% |
| 2019 | 1.07 Billion CNY | 73.32% |
| 2018 | 621.03 Million CNY | 25.87% |
| 2017 | 493.41 Million CNY | 30.12% |
| 2016 | 379.19 Million CNY | 19.43% |
| 2015 | 317.5 Million CNY | 32.59% |
| 2014 | 239.46 Million CNY | 49.04% |
| 2013 | 160.67 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 286.42 Million CNY | 6.23% |
| 2024 Q2 | 337.8 Million CNY | 17.94% |
| 2024 Q3 | 395.42 Million CNY | 19.18% |
| 2023 Q3 | 234.83 Million CNY | -5.89% |
| 2023 Q4 | 269.63 Million CNY | 14.82% |
| 2023 Q1 | 272.79 Million CNY | 146.42% |
| 2023 FY | 990.96 Million CNY | -9.93% |
| 2023 Q2 | 249.53 Million CNY | -8.53% |
| 2022 Q4 | 110.7 Million CNY | -65.3% |
| 2022 Q3 | 318.99 Million CNY | -1.41% |
| 2022 Q2 | 323.55 Million CNY | -6.74% |
| 2022 Q1 | 346.92 Million CNY | -38.74% |
| 2022 FY | 1.1 Billion CNY | -34.64% |
| 2021 Q4 | 566.34 Million CNY | 44.7% |
| 2021 Q3 | 391.38 Million CNY | -2.39% |
| 2021 FY | 1.68 Billion CNY | 23.53% |
| 2021 Q1 | 324.57 Million CNY | -20.96% |
| 2021 Q2 | 400.97 Million CNY | 23.54% |
| 2020 Q2 | 375.76 Million CNY | 87.5% |
| 2020 Q3 | 375.82 Million CNY | 0.02% |
| 2020 FY | 1.36 Billion CNY | 26.59% |
| 2020 Q1 | 200.41 Million CNY | -39.42% |
| 2020 Q4 | 410.62 Million CNY | 9.26% |
| 2019 Q2 | 272.38 Million CNY | 45.18% |
| 2019 FY | 1.07 Billion CNY | 73.32% |
| 2019 Q1 | 187.62 Million CNY | 9.44% |
| 2019 Q4 | 330.82 Million CNY | 15.85% |
| 2019 Q3 | 285.57 Million CNY | 4.84% |
| 2018 Q4 | 171.43 Million CNY | 7.51% |
| 2018 Q1 | 128.5 Million CNY | -0.33% |
| 2018 Q3 | 159.46 Million CNY | -1.34% |
| 2018 Q2 | 161.62 Million CNY | 25.78% |
| 2018 FY | 621.03 Million CNY | 25.87% |
| 2017 Q1 | 105.39 Million CNY | 11.07% |
| 2017 FY | 493.41 Million CNY | 30.12% |
| 2017 Q4 | 128.93 Million CNY | -5.43% |
| 2017 Q3 | 136.32 Million CNY | 11.05% |
| 2017 Q2 | 122.75 Million CNY | 16.48% |
| 2016 Q3 | 107.61 Million CNY | 0.0% |
| 2016 FY | 379.19 Million CNY | 19.43% |
| 2016 Q4 | 94.88 Million CNY | -11.83% |
| 2015 FY | 317.5 Million CNY | 32.59% |
| 2014 FY | 239.46 Million CNY | 49.04% |
| 2013 FY | 160.67 Million CNY | 0.0% |